Therefore, exogenous dysregulation of miR-188-5p in the MM cells triggered both cyclin/Rb/E2F-related signaling and Bcl-2/Bax/caspase-related pathway to modulate cell fate during tumor development. The gene discussed is BCL2; the disease is Miyoshi myopathy.